Recent Finacing
Recent Raise
Rivus Pharmaceuticals develops oral small-molecule Controlled Metabolic Accelerators that induce measured mitochondrial uncoupling to increase glucose and fat oxidation for obesity, NAFLD/NASH, type 2 diabetes, and HFpEF.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
